Defining and interpreting between-group differences in clinical trials of patients with osteoarthritis: Challenges and potential solutions

Key Points

• Clinical trials often struggle to define between-group differences effectively, impacting outcomes.
• Key evidence includes the necessity for robust statistical methods and clear interpretation that meet clinical relevance.
• Interpretation of data must consider multiple biomarkers and interventions to understand effects on osteoarthritis.
• Addressing these challenges is critical for improving treatment strategies and patient outcomes in osteoarthritis.